Becton, Dickinson and Company

(New York Stock Exchange)
Back to all articles
Slightly Bullish +15

Becton, Dickinson and Company (NYSE:BDX) CEO Thomas Polen, Jr. Sells ...

AI-generated analysis

πŸ“‰ CEO Thomas Polen, Jr. sold 4,152 shares for $768,120 on August 13th under a pre-arranged Rule 10b5-1 trading plan.

πŸ’° The company reported Q2 EPS of $3.23, beating the consensus estimate of $3.14 by $0.09.

πŸ“ˆ Revenue for the quarter reached $4.98 billion, surpassing the $4.89 billion consensus and growing 5.4% year-over-year.

πŸ’΅ The firm achieved a net margin of 4.52% and a return on equity of 14.79% during the reported period.

πŸ“… A quarterly dividend of $1.05 per share is scheduled for payment on September 30th to shareholders of record on September 9th.

🎯 Analyst Jefferies Financial Group reissued a 'buy' rating with a price target of $210.00 on August 6th.

πŸ“‰ Goldman Sachs lowered its price objective from $156.00 to $150.00 and maintained a neutral rating in May.

🏦 Bank of America reduced its price target from $177.00 to $170.00 in a June research note.

πŸ“Š The stock currently trades at a PEG ratio of 12.82 with a market capitalization of $50.47 billion.

πŸ›οΈ Institutional ownership stands at 86.97%, led by significant additions from Jupiter Topco LLC and Man Group plc.

Bullish Signals
  • The company beat quarterly earnings expectations with EPS of $3.23 versus the consensus of $3.14.
  • Revenue of $4.98 billion exceeded analyst estimates of $4.98 billion, demonstrating strong top-line performance.
  • Quarterly revenue grew 5.4% compared to the same quarter last year, indicating sustained business growth.
  • Jefferies Financial Group reissued a 'buy' rating with an ambitious price target of $210.00.
  • The company maintains a consistent dividend yield of 2.3% with a payout history supporting shareholder returns.
  • Major institutional investors like Jupiter Topco LLC added approximately $75.9 million to their positions in the second quarter.
Risk Factors
  • Goldman Sachs lowered its price objective from $156.00 to $150.00, signaling a more cautious outlook.
  • Bank of America reduced its price target from $177.00 to $170.00 in June, reflecting potential valuation concerns.
  • The stock carries a high PEG ratio of 12.82, suggesting the market may be pricing in significant future growth expectations that are difficult to meet.
  • The current trading price is below the 50-day moving average of $157.84 and the 200-day moving average of $161.70, indicating short-term weakness.
Full Analysis
Becton, Dickinson and Company (NYSE:BDX) CEO Thomas Polen, Jr. sold 4,152 shares of company stock on August 13th for a total transaction value of $768,120. The sale was executed under a pre-arranged Rule 10b5-1 trading plan, resulting in a 3.63% decrease in his personal position. Following the trade, the CEO retains ownership of 110,163 shares, valued at approximately $20.38 million. The company recently reported strong quarterly financial results announced on August 6th. Becton, Dickinson and Company posted earnings per share (EPS) of $3.23, beating the consensus estimate of $3.14, while revenue reached $4.98 billion against an expectation of $4.89 billion. The firm achieved a net margin of 4.52% and a return on equity of 14.79%, with quarterly revenue growing 5.4% year-over-year. Analyst sentiment remains mixed regarding the stock's valuation and future targets. While Jefferies Financial Group reissued a 'buy' rating with a $210 target, other major firms like Goldman Sachs and Bank of America have lowered their price objectives to neutral or hold ratings. The consensus price target stands at $185.67, slightly above the current trading price, reflecting varied outlooks on the medical technology sector. The company maintains a consistent dividend policy with an upcoming payment of $1.05 per share scheduled for September 30th to shareholders of record on September 9th. This represents a yield of 2.3% and an annualized dividend of $4.20. Institutional ownership remains high at 86.97%, with significant activity from investors like Jupiter Topco LLC and Man Group plc adding to their stakes during the second quarter.